ArticleBone marrow transplantation2024
Belumosudil and ruxolitinib combination for treatment of refractory chronic graft-versus-host disease.
Iskra Pusic et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
17 papers cite it
this papercites it